BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1281692)

  • 1. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Activation of B-CLL Cells.
    Defrance T; Fluckiger AC; Rossi JF; Rousset F; Banchereau J
    Leuk Lymphoma; 1991; 5 Suppl 1():13-9. PubMed ID: 27463474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.
    Rousset F; Garcia E; Banchereau J
    J Exp Med; 1991 Mar; 173(3):705-10. PubMed ID: 1705282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.
    Defrance T; Vanbervliet B; Brière F; Durand I; Rousset F; Banchereau J
    J Exp Med; 1992 Mar; 175(3):671-82. PubMed ID: 1371300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
    Söderberg O; Christiansen I; Carlsson M; Nilsson K
    Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in IgE isotype switching induced by anti-CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias.
    Takeuchi H; Kayano H; Hirose T
    Exp Hematol; 2000 May; 28(5):543-50. PubMed ID: 10812244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    Ranheim EA; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.
    Banchereau J; de Paoli P; Vallé A; Garcia E; Rousset F
    Science; 1991 Jan; 251(4989):70-2. PubMed ID: 1702555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
    Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
    Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
    Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
    Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
    Punnonen J; de Vries JE
    J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
    Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
    Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
    Crawford DH; Catovsky D
    Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative selection of human germinal center B cells by prolonged BCR cross-linking.
    Galibert L; Burdin N; Barthélémy C; Meffre G; Durand I; Garcia E; Garrone P; Rousset F; Banchereau J; Liu YJ
    J Exp Med; 1996 May; 183(5):2075-85. PubMed ID: 8642318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
    Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
    J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.